文献速递生殖医学

基于人工智能的光学显微镜静态图像胚胎 viability 评估模型开发

Development of an artificial intelligence-based assessment model for prediction of embryo viability using static images captured by optical light microscopy during IVF.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究利用11家IVF诊所2011–2018年8886枚第5天囊胚的静态光学显微镜图像和临床妊娠结局,开发了Life Whisperer人工智能模型。模型在三个独立盲测集中预测胚胎存活的敏感度为70.1%,特异度为60.5%,总体加权准确率>63%,合并准确率64.3%。与胚胎学家相比,二分类准确率提高24.7%(P=0.047),五级排名提高42.0%(P=0.028)。

要点

  • Life Whisperer AI模型利用第5天囊胚静态图像预测临床妊娠,合并准确率64.3%。
  • 模型预测敏感度70.1%、特异度60.5%,优于胚胎学家传统形态动力学分级。
  • 模型仅基于第5天胚胎开发,终点为临床妊娠而非活产,需前瞻性验证。

核心结论

  • Life Whisperer AI模型在预测第5天囊胚临床妊娠方面表现出优于胚胎学家的准确度,且具有跨诊所的稳健性和泛化能力。

研究设计与样本

  • 回顾性分析2011–2018年来自3个国家11家IVF诊所的8886枚胚胎的标准光学显微镜图像和临床妊娠结局。
  • AI模型使用已知临床妊娠结局(以胎心为准)的静态二维图像训练,提供妊娠预测置信评分。
  • 预测准确性通过敏感度、特异度和总体加权准确率评估,并与胚胎学家进行二分类和五级排名比较。

主要发现

  • 在三个独立盲测集中,模型预测存活胚胎的敏感度为70.1%,预测非存活胚胎的特异度为60.5%。
  • 每个盲测集的加权总体准确率均>63%,合并准确率为64.3%。
  • 预测分布显示正确分类与错误分类的胚胎有清晰分离。
  • 二分类比较显示模型比胚胎学家准确率提高24.7%(P=0.047,n=2,Student's t检验)。
  • 五级排名比较显示模型比胚胎学家提高42.0%(P=0.028,n=2,Student's t检验)。

临床怎么用

  • 该AI模型可辅助胚胎选择,可能提高IVF妊娠成功率,并促进多临床中心胚胎选择标准化。
  • 模型基于云端软件应用,无需复杂延时成像设备,便于在IVF诊所广泛推广。
  • 目前仅适用于第5天胚胎,且预测终点为临床妊娠(胎心),不能指示活产概率。
  • 需前瞻性数据评估模型在真实世界临床环境中的使用效果。

局限性

  • 模型仅限分析第5天胚胎,需进一步评估或修改以纳入不同时间点的信息。
  • 终点为临床妊娠(以胎心为准),不代表活产概率。
  • 研究采用回顾性收集的数据,需前瞻性收集数据评估真实世界应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can an artificial intelligence (AI)-based model predict human embryo viability using images captured by optical light microscopy? SUMMARY ANSWER: We have combined computer vision image processing methods and deep learning techniques to create the non-invasive Life Whisperer AI model for robust prediction of embryo viability, as measured by clinical pregnancy outcome, using single static images of Day 5 blastocysts obtained from standard optical light microscope systems. WHAT IS KNOWN ALREADY: Embryo selection following IVF is a critical factor in determining the success of ensuing pregnancy. Traditional morphokinetic grading by trained embryologists can be subjective and variable, and other complementary techniques, such as time-lapse imaging, require costly equipment and have not reliably demonstrated predictive ability for the endpoint of clinical pregnancy. AI methods are being investigated as a promising means for improving embryo selection and predicting implantation and pregnancy outcomes. STUDY DESIGN, SIZE, DURATION: These studies involved analysis of retrospectively collected data including standard optical light microscope images and clinical outcomes of 8886 embryos from 11 different IVF clinics, across three different countries, between 2011 and 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: The AI-based model was trained using static two-dimensional optical light microscope images with known clinical pregnancy outcome as measured by fetal heartbeat to provide a confidence score for prediction of pregnancy. Predictive accuracy was determined by evaluating sensitivity, specificity and overall weighted accuracy, and was visualized using histograms of the distributions of predictions. Comparison to embryologists' predictive accuracy was performed using a binary classification approach and a 5-band ranking comparison. MAIN RESULTS AND THE ROLE OF CHANCE: The Life Whisperer AI model showed a sensitivity of 70.1% for viable embryos while maintaining a specificity of 60.5% for non-viable embryos across three independent blind test sets from different clinics. The weighted overall accuracy in each blind test set was >63%, with a combined accuracy of 64.3% across both viable and non-viable embryos, demonstrating model robustness and generalizability beyond the result expected from chance. Distributions of predictions showed clear separation of correctly and incorrectly classified embryos. Binary comparison of viable/non-viable embryo classification demonstrated an improvement of 24.7% over embryologists' accuracy (P = 0.047, n = 2, Student's t test), and 5-band ranking comparison demonstrated an improvement of 42.0% over embryologists (P = 0.028, n = 2, Student's t test). LIMITATIONS, REASONS FOR CAUTION: The AI model developed here is limited to analysis of Day 5 embryos; therefore, further evaluation or modification of the model is needed to incorporate information from different time points. The endpoint described is clinical pregnancy as measured by fetal heartbeat, and this does not indicate the probability of live birth. The current investigation was performed with retrospectively collected data, and hence it will be of importance to collect data prospectively to assess real-world use of the AI model. WIDER IMPLICATIONS OF THE FINDINGS: These studies demonstrated an improved predictive ability for evaluation of embryo viability when compared with embryologists' traditional morphokinetic grading methods. The superior accuracy of the Life Whisperer AI model could lead to improved pregnancy success rates in IVF when used in a clinical setting. It could also potentially assist in standardization of embryo selection methods across multiple clinical environments, while eliminating the need for complex time-lapse imaging equipment. Finally, the cloud-based software application used to apply the Life Whisperer AI model in clinical practice makes it broadly applicable and globally scalable to IVF clinics worldwide. STUDY FUNDING/COMPETING INTEREST(S): Life Whisperer Diagnostics, Pty Ltd is a wholly owned subsidiary of the parent company, Presagen Pty Ltd. Funding for the study was provided by Presagen with grant funding received from the South Australian Government: Research, Commercialisation and Startup Fund (RCSF). 'In kind' support and embryology expertise to guide algorithm development were provided by Ovation Fertility. J.M.M.H., D.P. and M.P. are co-owners of Life Whisperer and Presagen. Presagen has filed a provisional patent for the technology described in this manuscript (52985P pending). A.P.M. owns stock in Life Whisperer, and S.M.D., A.J., T.N. and A.P.M. are employees of Life Whisperer.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. VerMilyea M, Hall JMM, Diakiw SM, et al. Development of an artificial intelligence-based assessment model for prediction of embryo viability using static images captured by optical light microscopy during IVF. Hum Reprod. 2020. PMID: 32240301. doi:10.1093/humrep/deaa013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。